Immuneering IMRX
NASDAQ IMRX
$4.07 +0.04 (+0.99%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immuneering (IMRX) Interest & Investment Income (2020 - 2026)

Updated

Immuneering (IMRX) recorded Interest & Investment Income of $1.08 million in Q2 2026, up 234.2% from $324,013 a year earlier but down 20.4% from the prior quarter.

Analysis

Immuneering (IMRX) Interest & Investment Income (2020 - 2026) Analysis & Trends

On a TTM basis, Immuneering's Interest & Investment Income came in at $4.72 million as of Jun 30, 2026, up 173.7% year-over-year; for FY2025, it came in at $3.04 million, up 17.2% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 134.7% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $2.59 million in FY2024 (-28.1%), $3.61 million in FY2023 (+255.6%), $1.01 million in FY2022 (+497.1%) and $169,899 in FY2021 (+298.3%).
  • Quarterly Interest & Investment Income has ranged from $17,400 in Q3 2021 to $1.86 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Interest & Investment Income has increased for three consecutive quarters, with growth averaging 72.7% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 716.6% in Q2 2023, against a decline of 60.8% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.36 million (Q1 2026), $1.86 million (Q4 2025) and $415,831 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Immuneering 263.32 Mn 263.32 Mn - 1.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.08 Mn
Mar 31, 2026 1.36 Mn
Dec 31, 2025 1.86 Mn
Sep 30, 2025 415,831.00
Jun 30, 2025 324,013.00
Mar 31, 2025 438,520.00
Dec 31, 2024 415,240.00
Sep 30, 2024 547,072.00
Jun 30, 2024 826,104.00
Mar 31, 2024 804,884.00
Dec 31, 2023 754,144.00
Sep 30, 2023 855,532.00
Jun 30, 2023 1.17 Mn
Mar 31, 2023 831,274.00
Dec 31, 2022 516,168.00
Sep 30, 2022 222,985.00
Jun 30, 2022 142,799.00
Mar 31, 2022 132,506.00
Dec 31, 2021 142,885.00
Sep 30, 2021 17,400.00
API Access

Immuneering Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=IMRX&period=max&api_key=YOUR_API_KEY